MYLAN LABS LTD Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYLAN LABS LTD, and what generic and branded alternatives to MYLAN LABS LTD drugs are available?
MYLAN LABS LTD has one hundred and forty-seven approved drugs.
There are nine tentative approvals on MYLAN LABS LTD drugs.
Drugs and US Patents for MYLAN LABS LTD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Labs Ltd | SUMATRIPTAN SUCCINATE | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 203322-001 | Apr 14, 2014 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Mylan Labs Ltd | DESOGESTREL AND ETHINYL ESTRADIOL | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 202085-001 | May 20, 2015 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Mylan Labs Ltd | CARMUSTINE | carmustine | INJECTABLE;INJECTION | 215368-001 | Mar 3, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Mylan Labs Ltd | CABAZITAXEL | cabazitaxel | SOLUTION;INTRAVENOUS | 207381-001 | Jul 5, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.